Ectopic expression of DNA encoding IFN-alpha 1 in the cornea protects mice from herpes simplex virus type 1-induced encephalitis.
A novel approach to combat acute herpes simplex virus type 1 (HSV-1) infection has recently been developed by administration with a plasmid DNA construct encoding cytokine genes. Cytokines, especially type I IFNs (IFN-alpha and IFN-beta) play an important role in controlling acute HSV-1 infection. The purpose of the present study was to investigate the potential efficacy of ectopically expressed IFN-alpha 1 against ocular HSV-1 infection following in situ transfection of mouse cornea with a naked IFN-alpha 1-containing plasmid DNA. Topical administration of the IFN-alpha 1 plasmid DNA exerted protection against ocular HSV-1 challenge in a time- and dose-dependent manner and antagonized HSV-1 reactivation. In addition, IFN-alpha 1-transfected eyes expressed a fivefold increase in MHC class I mRNA over vector-treated controls. The protective efficacy of the IFN-alpha 1 transgene antagonized viral replication, as evidenced by the reduction of the viral gene transcripts (infected cell polypeptide 27, thymidine kinase, and viral protein 16) and viral load in eyes and trigeminal ganglia during acute infection. The administration of neutralizing Ab to IFN-alpha beta antagonized the protective effect of the IFN-alpha 1 transgene in mice. Collectively, these findings demonstrate the potential of using naked plasmid DNA transfection in the eye to achieve ectopic gene expression of therapeutically active agents.
Noisakran
S
S
Department of Microbiology, Immunology, and Parasitology, Louisiana State University Medical Center, New Orleans, LA 70112, USA.
Campbell
I L
IL
Carr
D J
DJ
D000818:Animals; D019138:Antibodies, Blocking / Q000494:pharmacology; D002522:Chlorocebus aethiops; D003315:Cornea / Q000276:immunology* / Q000378:metabolism* / Q000821:virology; D016207:Cytokines / Q000235:genetics; D004247:DNA / Q000096:biosynthesis* / Q000276:immunology; D018792:Encephalitis, Viral / Q000276:immunology / Q000517:prevention & control*; D005260:Female; D006561:Herpes Simplex / Q000276:immunology / Q000517:prevention & control*; D018259:Herpesvirus 1, Human / Q000276:immunology*; D016898:Interferon-alpha / Q000008:administration & dosage / Q000235:genetics* / Q000276:immunology; D051379:Mice; D008813:Mice, Inbred ICR; D010957:Plasmids / Q000008:administration & dosage / Q000096:biosynthesis / Q000276:immunology; D014158:Transcription, Genetic / Q000276:immunology; D014162:Transfection; D014709:Vero Cells; D014775:Virus Activation / Q000276:immunology
D019138:Antibodies, Blocking; D016207:Cytokines; D016898:Interferon-alpha; D004247:DNA